RxDoctor Payments DataLook up a doctor →

Gregory Oldford, MD

Urology · West Bloomfield, MINPI 1376508762

Payments from drug & device makers

$28,437in general payments, 2019–2025

Across 488 payments — averaging $58.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$20K
  • Sumitomo Pharma America, Inc.$962
  • Antares Pharma, Inc.$855
  • Pfizer$702
  • AbbVie$601
  • Myriad Genetic Laboratories, Inc.$517
  • plus $4K from 41 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Astellas Pharma US Inc83$20,310
Sumitomo Pharma America, Inc.64$962
Antares Pharma, Inc.49$855
Pfizer38$702
AbbVie(2 entities)34$601
Myriad Genetic Laboratories, Inc.23$517
Ferring Pharmaceuticals Inc.17$416
Merck13$320
Teleflex LLC6$294
Laborie Medical Technologies Corp.7$272
Johnson & Johnson10$256
Urovant Sciences Inc13$204
AstraZeneca11$193
Dendreon Pharmaceuticals LLC8$177
Olympus America Inc.8$177
Tolmar Pharmaceuticals, Inc.10$173
Verity Pharmaceuticals Inc.8$161
Novartis6$153
Coloplast8$148
Photocure Inc3$120
180 Medical, Inc.5$107
Endo Pharmaceuticals Inc.6$107
Medtronic5$106
Axonics, Inc.5$101
Halozyme Inc4$94
Urogen Pharma, Inc.4$84
Caldera Medical, Inc1$84
Blue Earth Diagnostics4$83
Endo USA, Inc.4$83
Immunitybio, Inc.3$74
Boston Scientific3$60
Amgen4$60
Calyxo, Inc.3$60
Clarus Therapeutics Inc.3$54
Neotract Inc.2$37
Mission Pharmacal Company1$30
Zyla Life Sciences, Inc.2$25
Accord Healthcare, Inc.1$24
Progenics Pharmaceuticals, Inc.1$24
Myovant Sciences Inc.1$23
Azurity Pharmaceuticals, Inc.1$20
Sun Pharmaceutical Industries Inc.1$17
Bayer1$15
Angiodynamics, Inc.1$14
Avation Medical, Inc.1$14
Cook Medical LLC1$14
Acerus Pharmaceuticals Corporation1$13

How this compares

$28,437 in reported general payments places this provider in the 90th percentile of 400 urology providers in Michigan.

See all urology providers in Michigan →

Medicare billing

Part B allowed, 2024
$620,172
Medicare patients
1,251
Services billed
16,078

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other urology in West Bloomfield

See the full list for Michigan →

Where these figures come from

Is this you, or does something look wrong? →